NY POST | LA-based startup pushing male contraceptive raises $200K in new funding
ORIGINALLY POSTED ON NY POST
A Los Angeles-based startup for a male contraceptive injection that blocks the movement of sperm raised $200,000 in a fresh round of funding, the company said.
NEXT Life Sciences said the infusion of cash from the Male Contraceptive Initiative (MCI) will continue funding the development of its product, called Plan A.
MCI, the largest nonprofit dedicated to advancing male contraception, initially awarded NEXT a two-year grant in 2024.
Following a thorough review of the company’s progress, MCI unanimously approved the second year’s installment of $200,000, bringing the total grant funding for Plan A to $400,000.